The U.S. Food and Drug Administration has approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift…
Using human induced pluripotent stem cells (hiPSCs), researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California,…
